Since going public in October of 2020, Palantir is up an incredible 1,105% and trades at a mind-boggling 200 times forward ...

MongoDB shows bullish technicals but faces weakened fundamentals with declining growth. See why now may be the time to sell ...

Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...

Ascendis Pharma beat Q4 earnings and revenue estimates, driven by a $100M Novo Nordisk deal and Yorvipath's EU launch.

Coinbase stock is tumbling Friday as investors take profits following the crypto platform's impressive fourth-quarter results ...

In fact, the rise of off-exchange trading is widespread, affecting lots of stocks that mutual funds are also trying to buy in large quantities. Off-exchange trading is over 45% for all market caps, ...

Blue Bird Corporation remains a “Strong Buy” due to its solid backlog, strong funding, and undervaluation, despite recent ...

Shares of Gilead Sciences Inc. advanced 7.46% to $103.31 Wednesday, on what proved to be an all-around poor trading session ...

Roku’s momentum continues to build. The company recently reported that its global streaming TV household count reached..

Neurocrine Biosciences Inc. (NASDAQ:NBIX) reported fourth-quarter adjusted EPS of $1.69, higher than the $1.54 reported a ...